Myriad Genetics Inc (MYGN)
Current ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 298,000 | 293,200 | 291,600 | 290,300 | 313,600 | 265,400 | 294,300 | 261,600 | 274,600 | 352,300 | 367,100 | 427,400 | 484,800 | 498,900 | 538,900 | 329,200 | 389,400 | 394,500 | 331,700 | 355,200 |
| Total current liabilities | US$ in thousands | 164,100 | 154,300 | 148,900 | 146,100 | 155,900 | 209,300 | 221,100 | 143,300 | 137,200 | 129,100 | 119,700 | 166,000 | 204,300 | 203,200 | 271,000 | 149,000 | 145,900 | 133,700 | 147,000 | 113,200 |
| Current ratio | 1.82 | 1.90 | 1.96 | 1.99 | 2.01 | 1.27 | 1.33 | 1.83 | 2.00 | 2.73 | 3.07 | 2.57 | 2.37 | 2.46 | 1.99 | 2.21 | 2.67 | 2.95 | 2.26 | 3.14 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $298,000K ÷ $164,100K
= 1.82
Myriad Genetics Inc's current ratio has exhibited fluctuations over the past few years. The company's current ratio, which measures its ability to cover short-term liabilities with its current assets, peaked at 3.14 on March 31, 2020, indicating a strong liquidity position. However, the ratio declined to 1.33 on June 30, 2023, signaling a potential strain on the company's short-term financial obligations. Subsequently, the current ratio slightly recovered to 1.82 on December 31, 2024. Overall, the company's current ratio has shown varying levels of liquidity during the analyzed period, with some fluctuations possibly reflecting changes in the company's working capital management and financial health.
Peer comparison
Dec 31, 2024